Hematopoietic stem cells for treatment of ischemic brain injury
This study aims to test if injection of autologous hematopoietic cells (CD34+) can improve the neurologic evolution of pediatric patients with hypoxic/ischemic brain injury.
Read More
Product Information for
Hematopoietic stem cells for treatment of ischemic brain injury